Study identifier:NIS-CKR-DUM-2008/4
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
A retrospective, multi centre, non-interventional, observational study to compare treatment pattern and factors that affect BP control in patients with and without stroke
hypertension
-
No
-
All
1000
Observational
18 Years +
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verified 01 Jan 2015 by AstraZeneca Pharmaceuticals
AstraZeneca Pharmaceuticals
-
This study will compare hypertension treatment pattern of stroke patients with non-stroke patients receiving medical care from outpatient clinics at neurology specialty centers in Korea. It will evaluate target BP achievement rate in patients with stroke compared to patients without stroke and investigate factors affecting BP target goal efficacy in these patients.
Location
Location
Busan, Republic of Korea
Location
Deagu, Republic of Korea
Location
Deajeon, Republic of Korea
Location
Goyang, Gyeonggi, Republic of Korea
Location
Kwangju, Republic of Korea
Location
Seoul, Republic of Korea
Location
Sungnam, Gyeonggi, Republic of Korea
Location
Wonju, Kangwon, Republic of Korea
Arms | Assigned Interventions |
---|---|
1 Hypertension patients with history of stroke | - |
2 Hypertension patients without history of stroke | - |
This information is not intended to replace the informed medical advice or medical treatments of a healthcare professional. Only a physician can determine if a specific medicine is the correct treatment for a particular patient. If you have questions regarding any information contained in this site, you must consult a suitably qualified healthcare professional. Before prescribing any AstraZeneca products, Healthcare Professionals should view their country specific information.